Vancomycin 265/309 (85.8%) 76/265 (25.3%) 198/309 (64.1%) † Clinical cure is resolution of diarrhea following the recommended dose of drug (fidaxomicin: 200 mg twice a day; vancomycin: 125 mg ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...

A C. diff (Clostridioides difficile) diet may help alleviate diarrhea (the primary symptom) that is associated with this ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upgrading its current co-marketing ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers.

Meanwhile, A new report from the Health Protection Surveillance Centre (HPSC) found that 605 cases of C diff were reported last October, November and December. Of these cases, 272 were deemed to be ...